http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010049198-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea5ddac9cae108a5f80101c3f50a351
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-02
filingDate 2000-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d0e0522e4f8c6c7834d1c467f24576f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba2ab054cc36f87ceb43f948d9e0993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8501e0b37a26a2d37321cd7ccff51602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_407bc7939161b1498570da5a83e29250
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0282e6055df483834bdf9ae7c005a040
publicationDate 2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20010049198-A
titleOfInvention A purifying process of 4'-epi-doxorubicin
abstract The present invention relates to a method for purifying 4'-epi-doxorubicin, and more particularly, after adjusting the pH in a 4′-epi-doxorubicin crude product solution, it is applied to an adsorption resin or preparative liquid chromatography. The present invention relates to a method for purifying 4′-epi-doxorubicin, including a step of selectively adsorbing epi-doxorubicin, followed by elution, concentrating the eluate with a reverse osmosis system, and crystallizing only ethanol in a concentrator.n n n According to the present invention, 4'-epi-doxorubicin can be purified up to 99.7% in high purity, significantly improving the drug efficacy, preventing side effects caused by impurities, and also can be purified in high yield, which is very economical. It was found that there is an excellent effect. In addition, according to the purification method according to the present invention, by concentrating rapidly by the reverse osmosis membrane, and at a low temperature it was possible to prevent denaturation of the material by heat, and crystallization only with ethanol can prevent side effects due to toxic residual solvent, etc. I could see that. In addition, since the resin used in the present invention can be reused by repeated washing with an organic solvent, it can be seen that it is more economical.
priorityDate 1999-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448981304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22242641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451370557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15930782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502

Total number of triples: 41.